Dr Curtis Dobson (PhD) - personal details

I am a University of Manchester academic with a strong interest in the commercial exploitation of my research and in collaborations with industry.  

My post-doctoral research led to my founding Ai2 Ltd in 2005, and I was CEO of that company until 2009, leading the company's rapid growth over that period, and raising over £2.5m to develop the company's technology.  Over that time Ai2 worked closely with the global medical device industry and carried out over ten funded R&D projects with US and EU companies.  My work was judged North West Biotechnology Project of the Year for 2004, and Ai2 voted North West Biotechnology Start-Up of the Year 2005.  Ai2 continues to grow having recently secured its first major commercial deal, and in December 2011 receiving £1.75m investment. 

In my academic work I pursue research relating to the interactions between host proteins, microbes and medical device surfaces.  I collaborate with leading research groups, clinicians and companies in the UK and in the US, and consult for several multinational device manufacturers.